The plasma trade is becoming ever-more hypocritical
Reliance on America grows, as other countries clutch their pearls
An unusual sort of business will soon open in Shelby, North Carolina. It will take over premises previously run by a flooring company, tucked in beside shops selling clothes, paint and fast food. But it will not sell anything itself. Instead, willing donors, paid around $40 a pop, will sit connected to an apheresis machine. Over the course of an hour, the machine will extract their blood, siphon out plasma and recirculate the remaining fluid. The plasma will then be made into medicines, such as clotting factors for haemophiliacs and intravenous immunoglobulins for those suffering from autoimmune diseases.
Explore more
This article appeared in the Finance & economics section of the print edition under the headline “Blood boom”
Finance & economics August 31st 2024
- Inflation is down and a recession is unlikely. What went right?
- Are American rents rigged by algorithms?
- The plasma trade is becoming ever-more hypocritical
- How Vladimir Putin hopes to transform Russian trade
- Can Japan’s zombie bond market be brought back to life?
- Vast government debts are riskier than they appear
Discover more
Trump wastes no time in reigniting trade wars
Canada and Mexico look likely to suffer
How Trump, Starmer and Macron can avoid a debt crunch
With deficits soaring, their finance ministers will have to be smart
What Scott Bessent’s appointment means for the Trump administration
The president-elect’s nominee for treasury secretary faces a gruelling job
What Donald Trump and Bernie Sanders get wrong about credit cards
Forget interest rates. Rewards are the real problem
Computers unleashed economic growth. Will artificial intelligence?
Two years after ChatGPT-3.5 arrived, progress has been slower than expected
Should investors just give up on stocks outside America?
No, but it is getting a lot harder to keep the faith